Publication | Open Access

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Acute Lung InjuryPlacebo-controlled Phase 3Acute CarePatient SafetySepsisAcute MedicineMedicineHeparinsEmergency Medicine